"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Antihyperglycemics
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Hypoglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 3 | 6 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 2 | 2 |
| 2000 | 3 | 3 | 6 |
| 2001 | 1 | 3 | 4 |
| 2002 | 4 | 2 | 6 |
| 2003 | 3 | 2 | 5 |
| 2004 | 4 | 1 | 5 |
| 2005 | 5 | 4 | 9 |
| 2006 | 6 | 4 | 10 |
| 2007 | 3 | 4 | 7 |
| 2008 | 4 | 5 | 9 |
| 2009 | 4 | 7 | 11 |
| 2010 | 2 | 5 | 7 |
| 2011 | 6 | 5 | 11 |
| 2012 | 3 | 1 | 4 |
| 2013 | 7 | 8 | 15 |
| 2014 | 10 | 8 | 18 |
| 2015 | 11 | 7 | 18 |
| 2016 | 7 | 3 | 10 |
| 2017 | 11 | 7 | 18 |
| 2018 | 5 | 10 | 15 |
| 2019 | 9 | 10 | 19 |
| 2020 | 2 | 5 | 7 |
| 2021 | 1 | 10 | 11 |
| 2022 | 3 | 4 | 7 |
| 2023 | 0 | 5 | 5 |
| 2024 | 10 | 9 | 19 |
| 2025 | 14 | 7 | 21 |
| 2026 | 8 | 2 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes. Diabetes Res Clin Pract. 2026 Sep; 239:113503.
-
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes. Am J Kidney Dis. 2026 Sep; 88(3):366-377.
-
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. BMJ Open Diabetes Res Care. 2026 May 21; 14(3).
-
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study. Endocr Pract. 2026 Sep; 32(9):1353-1361.
-
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. BMJ Open Diabetes Res Care. 2026 Feb 26; 14(1).
-
Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial. JAMA. 2026 Feb 03; 335(5):407-415.
-
Lower Extremity Complications in Adults With Type 2 Diabetes Treated With Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas: An Emulated Target Trial. Endocr Pract. 2026 Jun; 32(6):916-926.
-
Association of Metformin Use and New-Onset International Classification of Diseases Coding of Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2026 Jun; 10(6):642-650.
-
Association Between Metformin and Other Diabetic Medications and Five-year Onset of New Neovascular Age-related Macular Degeneration Diagnosis. Ophthalmic Surg Lasers Imaging Retina. 2026 Feb; 57(2):102-111.
-
Effects of glucagon-like peptide-1 receptor agonists on male reproductive hormones, semen parameters, and metabolic outcomes: a systematic review. J Sex Med. 2026 Jan 07; 23(2).